Israel Showcases Iron Dome for Indians
Sources inform "Globes" that senior executives from Brainsway Ltd. (TASE:BRIN) are currently in the US holding talks with potential distributors for its product. Last month, Brainsway obtained US Food and Drug Administration (FDA) approval to use the company's Deep TMS (transcranial magnetic stimulation) device for the treatment of depression in patients who fail to respond to medication during a depression episode.Oral insulin developer Oramed to list on Nasdaq
The company is likely to sign a distribution agreement before it moves ahead with plans for a Nasdaq offering
Samsung Electronics has unveiled a $100 million seed fund to support innovation in components and subsystems related to its broad product line of TVs, mobile phones, computers and other digital devices. Chief strategy officer Young Sohn said that the fund would be focused on Silicon Valley, Cambridge, Mass., and Israel, but could also fund initiatives elsewhere in the world.
NCR Corporation has completed its $650 million cash acquisition of Israeli retail software developer Retalix Ltd.